Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib Treatment

  1. Parra-Guillen, Z.P.
  2. Berger, P.B.
  3. Haschke, M.
  4. Donzelli, M.
  5. Winogradova, D.
  6. Pfister, B.
  7. Früh, M.
  8. Gillessen, S.
  9. Krähenbühl, S.
  10. Kloft, C.
  11. Joerger, M.
Aldizkaria:
Basic and Clinical Pharmacology and Toxicology

ISSN: 1742-7843,  1742-7835

Argitalpen urtea: 2017

Alea: 121

Zenbakia: 4

Orrialdeak: 309-315

Mota: Artikulua

DOI: 10.1111/BCPT.12801 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus